News, Rx
Abstract
New clinical trial results were announced for the first-ever large-scale, prospective trial exclusively designed to compare the effects of statins in African-Americans, who are generally under represented in clinical trials. Data from the ARIES (African American Rosuvastatin Investigation of Efficacy and Safety) trial were presented at the American Heart Association's Annual Scientific Sessions in New Orleans. The Association of Black Cardiologists (ABC) partnered with AstraZeneca on the ARIES trial and played a pivotal role with patient and investigator recruitment, site support and patient and physician education.
| Export/Citation: | EndNote | BibTeX | Dublin Core | ASCII (Chicago style) | HTML Citation | OpenURL | Reference Manager |
| Social Networking: |
| Item Type: | Article |
|---|---|
| Additional Information: | Access to full text is subject to the publisher's access restrictions. |
| Uncontrolled Keywords: | statins, African Americans, cardiologists |
| Subjects: | Health > Public Health > Chronic Illness & Diseases > Cardiovascular Disease Health > Public Health > Health Risk Factors Research > studies |
| Related URLs: | |
| Depositing User: | Kismet Loftin-Bell |
| Date Deposited: | 17 Aug 2005 |
| Last Modified: | 14 Jun 2011 10:02 |
| Link to this item (URI): | http://health-equity.pitt.edu/id/eprint/159 |
Actions (login required)
| View Item |
![[feed]](http://health-equity.pitt.edu/images/feed-icon-32x32.png){kind=icon}